VVOS Earnings

Quarterly EPS
$-0.40
Q3 2024
$-0.36
Q4 2024
$-0.45
Q1 2025
$-0.55
Q2 2025
$-0.49
Q3 2025
$-0.55
Q4 2025
$-0.52
Q1 2026
$-0.31
Q2 2026
Latest Revenue5.2M
Latest Net Income-5523000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.315.2M-5523000+34.9%+43.6%
Q1 2026-$0.525.1M-7751000+70.5%-15.6%
Q4 2025-$0.553.8M-6954000+3.4%-52.8%
Q3 2025-$0.496.8M-5400000+75.7%-22.5%
Q2 2025-$0.553.8M-5013000-5.8%+8.3%
Q1 2025-$0.453.0M-3864000-11.8%+72.4%
Q4 2024-$0.363.7M-2827000+13.9%+87.4%
Q3 2024-$0.403.9M-2616000+16.9%+77.1%
Q2 2024-$0.604.1M-1930000——
Q1 2024-$1.633.4M-3763000——
Q4 2023-$2.853.2M-4259000——
Q3 2023-$1.753.3M-2093000——
Vivos Therapeutics (VVOS) — Earnings